Analysts Conflicted on These Healthcare Names: Axsome Therapeutics (AXSM), Waters (WAT) and Cingulate Inc (CING)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Axsome Therapeutics (AXSM – Research Report), Waters (WAT – Research Report) and Cingulate Inc (CING – Research Report).
Confident Investing Starts Here:
Axsome Therapeutics (AXSM)
In a report issued on May 16, Vikram Purohit from Morgan Stanley maintained a Buy rating on Axsome Therapeutics, with a price target of $190.00. The company's shares closed last Friday at $107.53.
According to TipRanks.com, Purohit 's ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -7.5% and a 30.9% success rate. Purohit covers the Healthcare sector, focusing on stocks such as Recursion Pharmaceuticals, BioMarin Pharmaceutical, and Arcutis Biotherapeutics.
Currently, the analyst consensus on Axsome Therapeutics is a Strong Buy with an average price target of $177.85, a 66.6% upside from current levels. In a report issued on May 1, Mizuho Securities also maintained a Buy rating on the stock with a $210.00 price target.
Waters (WAT)
Bank of America Securities analyst Michael Ryskin reiterated a Hold rating on Waters yesterday and set a price target of $370.00. The company's shares closed last Friday at $359.48.
According to TipRanks.com, Ryskin is a 2-star analyst with an average return of 0.2% and a 45.0% success rate. Ryskin covers the Healthcare sector, focusing on stocks such as Maravai Lifesciences Holdings, West Pharmaceutical Services, and Fortrea Holdings Inc.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Waters with a $393.77 average price target, representing an 11.9% upside. In a report issued on May 6, TD Cowen also maintained a Hold rating on the stock with a $375.00 price target.
Cingulate Inc (CING)
In a report released yesterday, Boobalan Pachaiyappan from Roth MKM reiterated a Buy rating on Cingulate Inc, with a price target of $11.00. The company's shares closed last Friday at $3.82, close to its 52-week low of $1.80.
According to TipRanks.com, Pachaiyappan has 0 stars on 0-5 stars ranking scale with an average return of -9.8% and a 31.5% success rate. Pachaiyappan covers the Healthcare sector, focusing on stocks such as Reviva Pharmaceuticals Holdings, Entrada Therapeutics Inc, and Gain Therapeutics.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
11 hours ago
- Business Insider
Analysts Offer Insights on Technology Companies: Sensata (ST) and Develop Global Limited (OtherVTEXF)
There's a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Sensata (ST – Research Report) and Develop Global Limited (VTEXF – Research Report) with bullish sentiments. Confident Investing Starts Here: Sensata (ST) TD Cowen analyst Joseph C Giordano maintained a Buy rating on Sensata yesterday and set a price target of $45.00. The company's shares closed last Monday at $25.70, close to its 52-week low of $24.42. According to Giordano is a 5-star analyst with an average return of 7.7% and a 60.7% success rate. Giordano covers the Industrial Goods sector, focusing on stocks such as Watts Water Technologies, Veralto Corporation, and Rockwell Automation. Currently, the analyst consensus on Sensata is a Hold with an average price target of $28.30. Develop Global Limited (VTEXF) In a report issued on May 29, Tim McCormack from Canaccord Genuity maintained a Buy rating on Develop Global Limited, with a price target of A$5.05. The company's shares closed last Tuesday at $1.40. According to McCormack is a top 100 analyst with an average return of 22.7% and a 66.5% success rate. McCormack covers the Basic Materials sector, focusing on stocks such as Northern Star Resources Ltd, Ramelius Resources Limited, and Gascoyne Resources Limited. Currently, the analyst consensus on Develop Global Limited is a Moderate Buy with an average price target of $2.92.
Yahoo
a day ago
- Yahoo
Maxine Waters campaign to pay $68K for violating campaign finance laws
Progressive California Rep. Maxine Waters' campaign has agreed to pay a $68,000 fine after an investigation found it violated multiple election rules. The Federal Election Commission (FEC) said the longtime House lawmaker's 2020 campaign committee, Citizens for Waters, ran afoul of several campaign finance laws in a tranche of documents released Friday. The FEC accused Citizens for Waters of "failing to accurately report receipts and disbursements in calendar year 2020," "knowingly accepting excessive contributions" and "making prohibited cash disbursements," according to one document that appears to be a legally binding agreement that allows both parties to avoid going to court. Dems Fume Over 'Due Process' For Abrego Garcia Despite Long History Of Party Bucking The Legal Principle Waters' committee agreed to pay the civil fine as well as "send its treasurer to a Commission-sponsored training program for political committees within one year of the effective date of this Agreement." "Respondent shall submit evidence of the required registration and attendance at such event to the Commission," the document said. Read On The Fox News App Citizens for Waters had accepted excessive campaign contributions from seven people totaling $19,000 in 2019 and 2020, the investigation found, despite the maximum legal individual contribution being capped at $2,800. The committee offloaded those excessive donations, albeit in an "untimely" fashion, the document said. Waters' campaign committee also "made four prohibited cash disbursements that were each in excess of $100, totaling $7,000," the FEC said. The campaign committee "contends that it retained legal counsel to provide advice and guidance to the treasurer and implemented procedures to ensure the disbursements comply with the requirements of the Act." Leilani Beaver, who was listed as Citizens for Waters' attorney, sent the FEC a letter last year that maintained the campaign finance violations were "errors" that "were not willful or purposeful." Waters, the top Democrat on the House Financial Services Committee, has served in Congress since 1991. The new movements in the probe were first reported by OpenSecrets. Maxine Waters Floats Deporting Melania Trump In Anti-doge Diatribe It is not the first time, however, that Waters has generated public scrutiny. In 2023, a Fox News Digital investigation found that Waters' campaign paid her daughter $192,300 to pay for a "slate mailer" operation between Jan. 2021 and Dec. 2022. It was reportedly just one sum out of thousands that Waters had paid her daughter for campaign work. A complaint that Waters' campaign had accepted illegal campaign contributions in 2018 was overwhelmingly dismissed by the FEC in a 5-1 vote. Fox News Digital reached out to Beavers, Waters' congressional office and Citizens for Waters for article source: Maxine Waters campaign to pay $68K for violating campaign finance laws
Business Insider
a day ago
- Business Insider
Analysts Offer Insights on Technology Companies: PagerDuty (PD) and AvePoint (AVPT)
Companies in the Technology sector have received a lot of coverage today as analysts weigh in on PagerDuty (PD – Research Report) and AvePoint (AVPT – Research Report). Confident Investing Starts Here: PagerDuty (PD) Monness analyst Brian White maintained a Hold rating on PagerDuty on May 30. The company's shares closed last Friday at $14.26. According to White is a top 100 analyst with an average return of 17.7% and a 67.1% success rate. White covers the Technology sector, focusing on stocks such as Salesforce, Snowflake, and MongoDB. Currently, the analyst consensus on PagerDuty is a Hold with an average price target of $18.70, implying a 24.8% upside from current levels. In a report issued on May 21, TD Cowen also maintained a Hold rating on the stock with a $18.00 price target. AvePoint (AVPT) The company's shares closed last Friday at $18.65, close to its 52-week high of $19.90. According to Wood is a 5-star analyst with an average return of 15.0% and a 62.4% success rate. Wood covers the Technology sector, focusing on stocks such as Onestream, Inc. Class A, Klaviyo, Inc. Class A, and Rimini Street. Currently, the analyst consensus on AvePoint is a Strong Buy with an average price target of $21.00.
